XOMA Announces Closing of the Offering and Exercise of Option
December 18 2013 - 04:01PM
XOMA Corporation (Nasdaq:XOMA) announced today the closing of the
offering of 10,925,000 shares of its common stock, including
1,425,000 shares of common stock that were issued upon the exercise
in full of the underwriters' option to purchase additional shares,
at a price to the public of $5.25 per share. The shares were sold
pursuant to a prospectus supplement filed as part of a shelf
registration statement previously filed with the Securities and
Exchange Commission (SEC) on Form S-3. XOMA anticipates its
aggregate net proceeds from the offering will be approximately
$53.5 million after deducting the underwriting discount and
estimated offering expenses payable by XOMA.
Credit Suisse Securities (USA) LLC and Jefferies LLC acted as
joint book running managers. Cowen and Company, LLC, Piper Jaffray
& Co. and RBC Capital Markets, LLC acted as co-managers. Piper
Jaffray & Co. served as financial advisor to XOMA.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About XOMA
XOMA discovers and develops innovative antibody
therapeutics.
CONTACT: XOMA Corporation
Company and Investor Contact:
Ashleigh Barreto
510-204-7482
barreto@xoma.com
Juliane Snowden
The Oratorium Group, LLC
jsnowden@oratoriumgroup.com
Media Contact:
Canale Communications
Carolyn Hawley
619-849-5375
carolyn@canalecomm.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Feb 2024 to Mar 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2023 to Mar 2024